tetano
Editor, Senior Moderator
Exp Ther Med
. 2022 Sep 26;24(5):691.
doi: 10.3892/etm.2022.11627. eCollection 2022 Nov.
Acute hepatitis and liver injury in hospitalized patients with COVID‑19 infection
Vasiliki Epameinondas Georgakopoulou[SUP] 1 [/SUP], Triada Bali[SUP] 2 [/SUP], Magdalini Adamantou[SUP] 2 [/SUP], Stavroula Asimakopoulou[SUP] 2 [/SUP], Sotiria Makrodimitri[SUP] 1 [/SUP], Stamatia Samara[SUP] 1 [/SUP], Maria Triantafyllou[SUP] 1 [/SUP], Pantazis M Voutsinas[SUP] 1 [/SUP], Irene Eliadi[SUP] 1 [/SUP], Georgios Karamanakos[SUP] 1 [/SUP], Dimitrios Basoulis[SUP] 1 3 [/SUP], Odysseas Chatzipanagiotou[SUP] 2 [/SUP], Eleni Adamopoulou[SUP] 2 [/SUP], Antonia Alevizou[SUP] 2 [/SUP], Menelaos Athanasiadis[SUP] 2 [/SUP], Demetrios A Spandidos[SUP] 4 [/SUP], Petros Papalexis[SUP] 2 [/SUP], Kyriakos Tarantinos[SUP] 5 [/SUP], Nikolaos V Sipsas[SUP] 1 3 [/SUP], Michael Samarkos[SUP] 1 2 [/SUP], Evangelos Cholongitas[SUP] 2 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is a systemic illness with an increased host inflammatory response that affects multiple extra-pulmonary organs, including the gastrointestinal tract. Abnormalities in liver biochemistry have been observed in a significant proportion of patients with COVID-19 upon admission, and this proportion increases with hospitalization. These abnormalities are typically manifested as elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, with less frequently detected elevations in the levels of cholestatic enzymes. Elevated aminotransaminase levels have been linked to an increased risk of mortality and complications, indicating the severity of COVID-19 infection. The present study evaluated the prevalence and the baseline factors associated with the development of acute hepatitis (ΑΗ), liver injury (LI) and associated patterns, as well as the presence of abnormalities in the levels of aminotransferases at discharge in the same cohort. For this purpose, 1,304 patients with confirmed COVID-19 infection were enrolled in the study. According to the results obtained, AST levels at baseline were the only independent factor for AH during hospital stay, while AST, alkaline phosphatase and ferritin levels were independent baseline factors for the development of LI. The patients with hepatocellular, compared to those with cholestatic LI, exhibited similar survival rates, as well as similarities in the development of acute kidney injury and the need for oxygen via high-flow nasal cannula and/or mechanical ventilation. In addition, age and ALT were independent risk factors for persistent abnormal values of AST and ALT at discharge.
Keywords: SARS-CoV-2; acute hepatitis; acute liver injury; coronavirus disease 2019; prognosis.
. 2022 Sep 26;24(5):691.
doi: 10.3892/etm.2022.11627. eCollection 2022 Nov.
Acute hepatitis and liver injury in hospitalized patients with COVID‑19 infection
Vasiliki Epameinondas Georgakopoulou[SUP] 1 [/SUP], Triada Bali[SUP] 2 [/SUP], Magdalini Adamantou[SUP] 2 [/SUP], Stavroula Asimakopoulou[SUP] 2 [/SUP], Sotiria Makrodimitri[SUP] 1 [/SUP], Stamatia Samara[SUP] 1 [/SUP], Maria Triantafyllou[SUP] 1 [/SUP], Pantazis M Voutsinas[SUP] 1 [/SUP], Irene Eliadi[SUP] 1 [/SUP], Georgios Karamanakos[SUP] 1 [/SUP], Dimitrios Basoulis[SUP] 1 3 [/SUP], Odysseas Chatzipanagiotou[SUP] 2 [/SUP], Eleni Adamopoulou[SUP] 2 [/SUP], Antonia Alevizou[SUP] 2 [/SUP], Menelaos Athanasiadis[SUP] 2 [/SUP], Demetrios A Spandidos[SUP] 4 [/SUP], Petros Papalexis[SUP] 2 [/SUP], Kyriakos Tarantinos[SUP] 5 [/SUP], Nikolaos V Sipsas[SUP] 1 3 [/SUP], Michael Samarkos[SUP] 1 2 [/SUP], Evangelos Cholongitas[SUP] 2 [/SUP]
Affiliations
- PMID: 36277149
- PMCID: PMC9535623
- DOI: 10.3892/etm.2022.11627
Abstract
Coronavirus disease 2019 (COVID-19) is a systemic illness with an increased host inflammatory response that affects multiple extra-pulmonary organs, including the gastrointestinal tract. Abnormalities in liver biochemistry have been observed in a significant proportion of patients with COVID-19 upon admission, and this proportion increases with hospitalization. These abnormalities are typically manifested as elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, with less frequently detected elevations in the levels of cholestatic enzymes. Elevated aminotransaminase levels have been linked to an increased risk of mortality and complications, indicating the severity of COVID-19 infection. The present study evaluated the prevalence and the baseline factors associated with the development of acute hepatitis (ΑΗ), liver injury (LI) and associated patterns, as well as the presence of abnormalities in the levels of aminotransferases at discharge in the same cohort. For this purpose, 1,304 patients with confirmed COVID-19 infection were enrolled in the study. According to the results obtained, AST levels at baseline were the only independent factor for AH during hospital stay, while AST, alkaline phosphatase and ferritin levels were independent baseline factors for the development of LI. The patients with hepatocellular, compared to those with cholestatic LI, exhibited similar survival rates, as well as similarities in the development of acute kidney injury and the need for oxygen via high-flow nasal cannula and/or mechanical ventilation. In addition, age and ALT were independent risk factors for persistent abnormal values of AST and ALT at discharge.
Keywords: SARS-CoV-2; acute hepatitis; acute liver injury; coronavirus disease 2019; prognosis.